| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 39 | 2025 | 1279 | 7.600 |
Why?
|
| Glucose | 50 | 2024 | 684 | 5.960 |
Why?
|
| Tumor Microenvironment | 30 | 2024 | 520 | 4.950 |
Why?
|
| Glucose Transporter Type 1 | 25 | 2022 | 45 | 4.830 |
Why?
|
| Neoplasms | 34 | 2024 | 3120 | 4.750 |
Why?
|
| Glycolysis | 46 | 2024 | 184 | 4.640 |
Why?
|
| Mitochondria | 34 | 2025 | 599 | 4.530 |
Why?
|
| Lymphocyte Activation | 26 | 2024 | 788 | 3.760 |
Why?
|
| Immunity | 6 | 2022 | 150 | 3.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 16 | 2024 | 626 | 3.200 |
Why?
|
| Energy Metabolism | 14 | 2023 | 302 | 2.970 |
Why?
|
| Proto-Oncogene Proteins c-akt | 19 | 2016 | 365 | 2.930 |
Why?
|
| Animals | 147 | 2025 | 28076 | 2.890 |
Why?
|
| Signal Transduction | 46 | 2024 | 3510 | 2.670 |
Why?
|
| Mice | 97 | 2025 | 12169 | 2.650 |
Why?
|
| T-Lymphocytes, Regulatory | 10 | 2023 | 333 | 2.590 |
Why?
|
| Apoptosis | 25 | 2021 | 1752 | 2.550 |
Why?
|
| Inflammation | 15 | 2025 | 1023 | 2.220 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2024 | 342 | 2.110 |
Why?
|
| Th17 Cells | 8 | 2024 | 95 | 2.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2025 | 463 | 2.020 |
Why?
|
| Immunotherapy | 15 | 2024 | 723 | 1.980 |
Why?
|
| Cell Differentiation | 23 | 2024 | 1591 | 1.970 |
Why?
|
| Kidney Neoplasms | 4 | 2024 | 528 | 1.890 |
Why?
|
| Homeostasis | 18 | 2021 | 450 | 1.850 |
Why?
|
| Metabolic Networks and Pathways | 9 | 2023 | 95 | 1.800 |
Why?
|
| B-Lymphocytes | 11 | 2024 | 754 | 1.750 |
Why?
|
| Fever | 2 | 2025 | 130 | 1.740 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 10 | 2021 | 149 | 1.700 |
Why?
|
| Mice, Inbred C57BL | 36 | 2025 | 3369 | 1.670 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 12 | 2020 | 209 | 1.630 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 10 | 2024 | 40 | 1.600 |
Why?
|
| Humans | 139 | 2025 | 92241 | 1.540 |
Why?
|
| Lymphocytes | 9 | 2023 | 479 | 1.500 |
Why?
|
| Stress, Physiological | 6 | 2025 | 247 | 1.490 |
Why?
|
| Obesity | 7 | 2025 | 1015 | 1.450 |
Why?
|
| Autophagy | 9 | 2017 | 169 | 1.420 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2022 | 283 | 1.420 |
Why?
|
| Cell Survival | 25 | 2021 | 1012 | 1.420 |
Why?
|
| Glutamine | 14 | 2024 | 95 | 1.420 |
Why?
|
| Cell Line, Tumor | 28 | 2024 | 2670 | 1.400 |
Why?
|
| Fatty Acids | 7 | 2025 | 149 | 1.360 |
Why?
|
| Glutaminase | 2 | 2021 | 13 | 1.330 |
Why?
|
| TOR Serine-Threonine Kinases | 13 | 2016 | 208 | 1.320 |
Why?
|
| Cell Proliferation | 20 | 2024 | 1720 | 1.250 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2011 | 679 | 1.250 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 2 | 2022 | 5 | 1.140 |
Why?
|
| Epigenesis, Genetic | 5 | 2022 | 538 | 1.130 |
Why?
|
| Chromatin | 3 | 2023 | 417 | 1.120 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2011 | 203 | 1.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 2016 | 140 | 1.090 |
Why?
|
| CD28 Antigens | 4 | 2020 | 93 | 1.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 188 | 1.050 |
Why?
|
| Immune System | 4 | 2023 | 103 | 1.030 |
Why?
|
| Macrophages | 8 | 2025 | 601 | 1.030 |
Why?
|
| Multiprotein Complexes | 7 | 2016 | 103 | 1.010 |
Why?
|
| Forkhead Transcription Factors | 4 | 2024 | 177 | 1.000 |
Why?
|
| Acetate-CoA Ligase | 2 | 2024 | 3 | 1.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2024 | 1310 | 0.970 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2012 | 187 | 0.960 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2024 | 31 | 0.920 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2024 | 9 | 0.910 |
Why?
|
| Interleukin-7 | 5 | 2020 | 47 | 0.900 |
Why?
|
| Cytokines | 10 | 2022 | 841 | 0.900 |
Why?
|
| DNA Damage | 3 | 2024 | 381 | 0.890 |
Why?
|
| Adaptation, Physiological | 2 | 2025 | 322 | 0.890 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2024 | 183 | 0.870 |
Why?
|
| Diazooxonorleucine | 1 | 2023 | 6 | 0.870 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2023 | 213 | 0.870 |
Why?
|
| Receptors, Transferrin | 1 | 2023 | 12 | 0.830 |
Why?
|
| Myelopoiesis | 1 | 2022 | 11 | 0.820 |
Why?
|
| Oxidative Phosphorylation | 6 | 2021 | 62 | 0.800 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2022 | 164 | 0.800 |
Why?
|
| Mice, Transgenic | 12 | 2021 | 1608 | 0.790 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 79 | 0.790 |
Why?
|
| STAT1 Transcription Factor | 1 | 2022 | 54 | 0.790 |
Why?
|
| Th1 Cells | 2 | 2024 | 168 | 0.790 |
Why?
|
| Disease Models, Animal | 16 | 2025 | 2459 | 0.770 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2021 | 5 | 0.770 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 547 | 0.770 |
Why?
|
| B-Cell Activating Factor | 3 | 2021 | 8 | 0.760 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2021 | 254 | 0.760 |
Why?
|
| Cells, Cultured | 16 | 2025 | 2911 | 0.750 |
Why?
|
| Purines | 1 | 2021 | 97 | 0.730 |
Why?
|
| Mice, Knockout | 19 | 2025 | 2088 | 0.730 |
Why?
|
| Interdisciplinary Research | 1 | 2021 | 7 | 0.720 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 430 | 0.710 |
Why?
|
| Nephritis | 1 | 2020 | 18 | 0.700 |
Why?
|
| Cell Lineage | 5 | 2024 | 302 | 0.680 |
Why?
|
| Molecular Targeted Therapy | 4 | 2018 | 291 | 0.660 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2018 | 277 | 0.650 |
Why?
|
| Membrane Proteins | 6 | 2011 | 1246 | 0.640 |
Why?
|
| Metabolomics | 5 | 2024 | 95 | 0.630 |
Why?
|
| Dexamethasone | 1 | 2021 | 347 | 0.620 |
Why?
|
| Phagocytosis | 3 | 2025 | 93 | 0.610 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2016 | 68 | 0.600 |
Why?
|
| Reactive Oxygen Species | 6 | 2024 | 507 | 0.590 |
Why?
|
| Asthma | 3 | 2024 | 1002 | 0.590 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2010 | 293 | 0.580 |
Why?
|
| Cystine | 2 | 2018 | 17 | 0.570 |
Why?
|
| Oxidation-Reduction | 7 | 2025 | 403 | 0.560 |
Why?
|
| Neutrophils | 4 | 2022 | 323 | 0.550 |
Why?
|
| Acetyl Coenzyme A | 3 | 2022 | 13 | 0.550 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 2015 | 76 | 0.550 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2024 | 814 | 0.550 |
Why?
|
| Rheumatic Diseases | 1 | 2017 | 28 | 0.540 |
Why?
|
| Interferon-gamma | 3 | 2017 | 453 | 0.540 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 30 | 0.530 |
Why?
|
| Immune Tolerance | 4 | 2022 | 355 | 0.530 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2023 | 7 | 0.520 |
Why?
|
| Biomedical Research | 1 | 2021 | 404 | 0.520 |
Why?
|
| Receptors, Estrogen | 3 | 2016 | 401 | 0.520 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2016 | 7 | 0.510 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 93 | 0.500 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 989 | 0.500 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2015 | 2 | 0.490 |
Why?
|
| Protein Kinase C-alpha | 1 | 2015 | 29 | 0.480 |
Why?
|
| Lipid Metabolism | 4 | 2025 | 212 | 0.480 |
Why?
|
| Graft vs Host Disease | 3 | 2022 | 365 | 0.470 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 63 | 0.460 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2024 | 21 | 0.450 |
Why?
|
| Clonal Anergy | 1 | 2014 | 32 | 0.440 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2014 | 73 | 0.440 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2013 | 111 | 0.440 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 137 | 0.440 |
Why?
|
| Single-Cell Analysis | 4 | 2024 | 172 | 0.430 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 235 | 0.430 |
Why?
|
| Antibody Formation | 1 | 2014 | 174 | 0.430 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 2017 | 29 | 0.420 |
Why?
|
| Immunity, Cellular | 3 | 2021 | 182 | 0.420 |
Why?
|
| Inflammation Mediators | 3 | 2024 | 162 | 0.420 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2020 | 95 | 0.390 |
Why?
|
| Sulfonamides | 4 | 2020 | 328 | 0.390 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 4 | 2017 | 43 | 0.380 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 407 | 0.380 |
Why?
|
| Flow Cytometry | 8 | 2016 | 704 | 0.370 |
Why?
|
| Adrenocortical Carcinoma | 2 | 2021 | 14 | 0.370 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2021 | 20 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 5 | 2024 | 1110 | 0.370 |
Why?
|
| Interleukin-10 | 2 | 2023 | 160 | 0.370 |
Why?
|
| Female | 32 | 2025 | 47837 | 0.370 |
Why?
|
| Nanoparticles | 2 | 2023 | 168 | 0.360 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 46 | 0.360 |
Why?
|
| Protein Kinases | 2 | 2009 | 215 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2017 | 139 | 0.350 |
Why?
|
| Immunophenotyping | 3 | 2024 | 221 | 0.350 |
Why?
|
| Carcinogenesis | 3 | 2024 | 222 | 0.350 |
Why?
|
| Cell Physiological Phenomena | 1 | 2010 | 25 | 0.350 |
Why?
|
| bcl-2-Associated X Protein | 7 | 2011 | 55 | 0.340 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2017 | 622 | 0.340 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2010 | 29 | 0.340 |
Why?
|
| Citric Acid Cycle | 3 | 2021 | 27 | 0.340 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 168 | 0.340 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 56 | 0.330 |
Why?
|
| Male | 22 | 2024 | 43877 | 0.330 |
Why?
|
| Immunologic Factors | 2 | 2021 | 175 | 0.320 |
Why?
|
| Hypertrophy | 1 | 2009 | 67 | 0.320 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2020 | 97 | 0.320 |
Why?
|
| PDZ Domains | 1 | 2009 | 16 | 0.320 |
Why?
|
| Cell Division | 7 | 2010 | 699 | 0.320 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 15 | 0.310 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 1171 | 0.310 |
Why?
|
| Adaptive Immunity | 3 | 2024 | 172 | 0.310 |
Why?
|
| Pyruvate Kinase | 1 | 2008 | 14 | 0.300 |
Why?
|
| Histones | 2 | 2019 | 350 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 331 | 0.300 |
Why?
|
| Receptors, Immunologic | 3 | 2025 | 142 | 0.300 |
Why?
|
| Hyperglycemia | 1 | 2009 | 176 | 0.290 |
Why?
|
| Melanoma | 3 | 2019 | 481 | 0.290 |
Why?
|
| Metabolome | 3 | 2021 | 61 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 408 | 0.290 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 44 | 0.290 |
Why?
|
| Immunologic Memory | 4 | 2021 | 176 | 0.290 |
Why?
|
| Amino Acid Transport System y+ | 2 | 2018 | 9 | 0.280 |
Why?
|
| Carbohydrate Metabolism | 3 | 2016 | 32 | 0.280 |
Why?
|
| Cell Line | 10 | 2018 | 2527 | 0.280 |
Why?
|
| Monitoring, Immunologic | 2 | 2018 | 19 | 0.280 |
Why?
|
| Germinal Center | 3 | 2024 | 61 | 0.280 |
Why?
|
| Autoimmunity | 3 | 2022 | 175 | 0.270 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2006 | 0.270 |
Why?
|
| Phosphorylation | 4 | 2022 | 1142 | 0.270 |
Why?
|
| Up-Regulation | 4 | 2016 | 731 | 0.270 |
Why?
|
| Kidney | 3 | 2024 | 1153 | 0.270 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 177 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2025 | 142 | 0.260 |
Why?
|
| Bcl-2-Like Protein 11 | 3 | 2011 | 25 | 0.260 |
Why?
|
| Interleukin-3 | 4 | 2008 | 40 | 0.260 |
Why?
|
| Drug Synergism | 3 | 2021 | 312 | 0.260 |
Why?
|
| Immunomodulation | 3 | 2021 | 61 | 0.260 |
Why?
|
| Phenotype | 4 | 2022 | 2502 | 0.250 |
Why?
|
| Leukemia | 2 | 2022 | 321 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2022 | 419 | 0.250 |
Why?
|
| Macrophages, Peritoneal | 2 | 2025 | 24 | 0.250 |
Why?
|
| Gene Deletion | 4 | 2020 | 351 | 0.250 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 208 | 0.250 |
Why?
|
| Membrane Glycoproteins | 2 | 2025 | 438 | 0.250 |
Why?
|
| Receptors, Scavenger | 1 | 2025 | 4 | 0.240 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2016 | 28 | 0.240 |
Why?
|
| Transcriptome | 4 | 2021 | 695 | 0.240 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2024 | 9 | 0.240 |
Why?
|
| Growth Substances | 1 | 2005 | 80 | 0.240 |
Why?
|
| Primary Cell Culture | 2 | 2024 | 80 | 0.240 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 2367 | 0.230 |
Why?
|
| Staphylococcal Infections | 2 | 2025 | 279 | 0.230 |
Why?
|
| Chemotaxis | 1 | 2005 | 74 | 0.230 |
Why?
|
| Models, Biological | 9 | 2017 | 1784 | 0.230 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2024 | 130 | 0.230 |
Why?
|
| Neoplastic Stem Cells | 2 | 2024 | 167 | 0.230 |
Why?
|
| Breast Neoplasms | 4 | 2025 | 3053 | 0.230 |
Why?
|
| B7-2 Antigen | 1 | 2024 | 40 | 0.230 |
Why?
|
| Receptors, Cell Surface | 2 | 2022 | 291 | 0.230 |
Why?
|
| Caspases | 3 | 2013 | 158 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2024 | 178 | 0.230 |
Why?
|
| Hedgehog Proteins | 2 | 2023 | 102 | 0.230 |
Why?
|
| Founder Effect | 1 | 2024 | 105 | 0.230 |
Why?
|
| Hot Temperature | 1 | 2025 | 213 | 0.220 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2025 | 80 | 0.220 |
Why?
|
| Biological Transport | 4 | 2023 | 410 | 0.220 |
Why?
|
| Neutropenia | 1 | 2024 | 217 | 0.220 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 735 | 0.220 |
Why?
|
| Embryonic Development | 1 | 2024 | 81 | 0.220 |
Why?
|
| Bone Resorption | 2 | 2022 | 44 | 0.220 |
Why?
|
| Culture Media, Conditioned | 1 | 2024 | 104 | 0.220 |
Why?
|
| Protein Kinase C-delta | 1 | 2023 | 29 | 0.220 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 120 | 0.220 |
Why?
|
| Jurkat Cells | 3 | 2018 | 81 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2021 | 573 | 0.220 |
Why?
|
| bcl-X Protein | 3 | 2010 | 56 | 0.220 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 2396 | 0.220 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 168 | 0.210 |
Why?
|
| Organ Specificity | 2 | 2024 | 283 | 0.210 |
Why?
|
| Malnutrition | 2 | 2014 | 35 | 0.210 |
Why?
|
| Phagocytes | 2 | 2023 | 14 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2024 | 461 | 0.210 |
Why?
|
| Parathyroid Glands | 1 | 2023 | 75 | 0.210 |
Why?
|
| Protein Transport | 4 | 2009 | 431 | 0.210 |
Why?
|
| Weight Loss | 1 | 2025 | 239 | 0.210 |
Why?
|
| Heterozygote | 1 | 2024 | 379 | 0.210 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 561 | 0.210 |
Why?
|
| Osteogenesis | 2 | 2022 | 270 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 2 | 2021 | 289 | 0.210 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 202 | 0.210 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 204 | 0.210 |
Why?
|
| Ventricular Myosins | 1 | 2022 | 5 | 0.210 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2022 | 5 | 0.210 |
Why?
|
| Antigen Presentation | 1 | 2024 | 217 | 0.200 |
Why?
|
| Lactic Acid | 2 | 2024 | 99 | 0.200 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2022 | 3 | 0.200 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2003 | 41 | 0.200 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 5 | 2011 | 19 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 14 | 0.200 |
Why?
|
| Osteoclasts | 1 | 2022 | 37 | 0.200 |
Why?
|
| Escherichia coli Infections | 1 | 2022 | 35 | 0.200 |
Why?
|
| Urinary Tract | 1 | 2022 | 35 | 0.190 |
Why?
|
| Myocarditis | 1 | 2022 | 56 | 0.190 |
Why?
|
| Cell Cycle Proteins | 3 | 2024 | 402 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 87 | 0.190 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 81 | 0.190 |
Why?
|
| Extracellular Traps | 1 | 2021 | 13 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 80 | 0.190 |
Why?
|
| Calgranulin B | 1 | 2021 | 16 | 0.190 |
Why?
|
| Methylamines | 1 | 2021 | 6 | 0.190 |
Why?
|
| Thyroid Gland | 1 | 2023 | 280 | 0.190 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 118 | 0.190 |
Why?
|
| Cell Death | 3 | 2008 | 267 | 0.190 |
Why?
|
| Tretinoin | 1 | 2022 | 131 | 0.190 |
Why?
|
| Syk Kinase | 1 | 2021 | 7 | 0.190 |
Why?
|
| Receptor, Notch2 | 1 | 2021 | 7 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2021 | 8 | 0.190 |
Why?
|
| Dinoprostone | 1 | 2021 | 72 | 0.180 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 475 | 0.180 |
Why?
|
| Alternaria | 1 | 2021 | 2 | 0.180 |
Why?
|
| Mast Cells | 1 | 2021 | 96 | 0.180 |
Why?
|
| Pyroglyphidae | 1 | 2021 | 15 | 0.180 |
Why?
|
| Amino Acids | 3 | 2021 | 255 | 0.180 |
Why?
|
| Proteins | 2 | 2020 | 804 | 0.180 |
Why?
|
| Receptors, Notch | 2 | 2016 | 132 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2021 | 682 | 0.180 |
Why?
|
| Interleukin-17 | 2 | 2019 | 107 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2022 | 272 | 0.180 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2022 | 119 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 2 | 2024 | 122 | 0.180 |
Why?
|
| Organic Chemicals | 1 | 2020 | 36 | 0.180 |
Why?
|
| Cellular Reprogramming | 2 | 2021 | 45 | 0.170 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2020 | 12 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 657 | 0.170 |
Why?
|
| Immunity, Innate | 2 | 2024 | 439 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 502 | 0.170 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 128 | 0.170 |
Why?
|
| Receptors, Antigen | 2 | 2019 | 13 | 0.170 |
Why?
|
| Dietary Fats | 1 | 2021 | 136 | 0.170 |
Why?
|
| Treatment Failure | 1 | 2021 | 287 | 0.170 |
Why?
|
| Transplantation, Homologous | 3 | 2021 | 1012 | 0.170 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 146 | 0.170 |
Why?
|
| Aerobiosis | 4 | 2018 | 21 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2022 | 377 | 0.170 |
Why?
|
| Adoptive Transfer | 3 | 2015 | 174 | 0.170 |
Why?
|
| Cell Hypoxia | 3 | 2021 | 179 | 0.170 |
Why?
|
| Th2 Cells | 1 | 2021 | 148 | 0.170 |
Why?
|
| Metabolism | 2 | 2016 | 26 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 442 | 0.170 |
Why?
|
| Hydrocortisone | 1 | 2021 | 304 | 0.170 |
Why?
|
| Computational Biology | 2 | 2021 | 562 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 90 | 0.160 |
Why?
|
| Receptors, Interleukin | 1 | 2019 | 38 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 814 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1899 | 0.160 |
Why?
|
| Leukemia, Myeloid | 1 | 2020 | 250 | 0.160 |
Why?
|
| Serotonin | 1 | 2020 | 219 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2019 | 43 | 0.160 |
Why?
|
| Methionine | 1 | 2019 | 68 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 927 | 0.150 |
Why?
|
| Immunoblotting | 4 | 2013 | 276 | 0.150 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 281 | 0.150 |
Why?
|
| Calcinosis | 1 | 2020 | 230 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 150 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2021 | 614 | 0.150 |
Why?
|
| Models, Immunological | 3 | 2010 | 84 | 0.150 |
Why?
|
| Glutamic Acid | 2 | 2016 | 156 | 0.150 |
Why?
|
| Carbon | 2 | 2016 | 96 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 157 | 0.150 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2018 | 2 | 0.150 |
Why?
|
| Rats | 4 | 2011 | 4077 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2011 | 318 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 922 | 0.150 |
Why?
|
| Mutation | 4 | 2024 | 4226 | 0.150 |
Why?
|
| Lung | 2 | 2024 | 1336 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 432 | 0.150 |
Why?
|
| Colon | 1 | 2021 | 527 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2020 | 260 | 0.140 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 109 | 0.140 |
Why?
|
| Transfection | 3 | 2011 | 914 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 69 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2013 | 701 | 0.140 |
Why?
|
| Skin | 2 | 2018 | 592 | 0.140 |
Why?
|
| Sepsis | 1 | 2021 | 350 | 0.140 |
Why?
|
| Spleen | 2 | 2016 | 434 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 893 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 1395 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2024 | 1074 | 0.140 |
Why?
|
| Drug Therapy | 1 | 2017 | 70 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2021 | 855 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2021 | 676 | 0.130 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 27 | 0.130 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 146 | 0.130 |
Why?
|
| Fluorescence | 1 | 2016 | 104 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 71 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 968 | 0.130 |
Why?
|
| Glutathione | 1 | 2016 | 105 | 0.130 |
Why?
|
| Lactates | 1 | 2016 | 37 | 0.130 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1575 | 0.130 |
Why?
|
| Cell Transformation, Viral | 1 | 2016 | 39 | 0.130 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2016 | 15 | 0.130 |
Why?
|
| Cell Size | 2 | 2008 | 71 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2015 | 800 | 0.130 |
Why?
|
| Biological Clocks | 1 | 2016 | 75 | 0.130 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 13 | 0.130 |
Why?
|
| Phosphoenolpyruvate | 1 | 2015 | 2 | 0.130 |
Why?
|
| CLOCK Proteins | 1 | 2015 | 16 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 610 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2021 | 829 | 0.120 |
Why?
|
| Receptors, IgG | 1 | 2015 | 56 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 1044 | 0.120 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 68 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2015 | 89 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 787 | 0.120 |
Why?
|
| Glycosphingolipids | 1 | 2015 | 4 | 0.120 |
Why?
|
| Desmoglein 3 | 1 | 2014 | 6 | 0.120 |
Why?
|
| Psoriasis | 1 | 2018 | 247 | 0.120 |
Why?
|
| Interleukin-2 | 3 | 2004 | 244 | 0.120 |
Why?
|
| Alopecia | 1 | 2014 | 35 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2014 | 48 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 260 | 0.120 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2014 | 3 | 0.110 |
Why?
|
| RNA Interference | 2 | 2015 | 382 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2008 | 687 | 0.110 |
Why?
|
| Dichloroacetic Acid | 1 | 2014 | 12 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1212 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 1846 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 201 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 86 | 0.110 |
Why?
|
| Methylation | 2 | 2019 | 280 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2041 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 2 | 2015 | 260 | 0.110 |
Why?
|
| Leptin | 1 | 2013 | 104 | 0.110 |
Why?
|
| Sarcoma | 1 | 2015 | 216 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3496 | 0.110 |
Why?
|
| Hexokinase | 3 | 2015 | 22 | 0.100 |
Why?
|
| Lipids | 2 | 2022 | 278 | 0.100 |
Why?
|
| Time Factors | 3 | 2024 | 5435 | 0.100 |
Why?
|
| Autoimmune Diseases | 2 | 2008 | 254 | 0.100 |
Why?
|
| Glioma | 1 | 2016 | 301 | 0.100 |
Why?
|
| Cell Separation | 2 | 2011 | 201 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2024 | 1684 | 0.100 |
Why?
|
| Piperazines | 2 | 2013 | 288 | 0.100 |
Why?
|
| Middle Aged | 6 | 2024 | 27039 | 0.100 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2012 | 1 | 0.100 |
Why?
|
| Young Adult | 2 | 2024 | 6606 | 0.100 |
Why?
|
| Organoids | 2 | 2023 | 70 | 0.100 |
Why?
|
| Thymus Gland | 2 | 2024 | 201 | 0.100 |
Why?
|
| Ubiquitination | 2 | 2011 | 79 | 0.100 |
Why?
|
| Binding Sites | 3 | 2015 | 1132 | 0.100 |
Why?
|
| Necrosis | 1 | 2012 | 209 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2011 | 111 | 0.100 |
Why?
|
| Biological Assay | 1 | 2012 | 81 | 0.100 |
Why?
|
| Hydroxycholesterols | 1 | 2011 | 7 | 0.100 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2011 | 15 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 10 | 0.090 |
Why?
|
| Nitrophenols | 1 | 2011 | 12 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2020 | 266 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 1 | 2012 | 109 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 27518 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 425 | 0.090 |
Why?
|
| Colitis | 1 | 2014 | 252 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 61 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 1770 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2011 | 18 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2022 | 560 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 32 | 0.090 |
Why?
|
| src Homology Domains | 1 | 2010 | 46 | 0.090 |
Why?
|
| Mitosis | 1 | 2011 | 154 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cytokinesis | 1 | 2011 | 59 | 0.090 |
Why?
|
| Lymphocyte Count | 1 | 2010 | 100 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 319 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 315 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2015 | 433 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 166 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2011 | 277 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 129 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2011 | 265 | 0.080 |
Why?
|
| Plasmids | 1 | 2010 | 293 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2024 | 553 | 0.080 |
Why?
|
| Cholesterol | 1 | 2011 | 361 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2010 | 105 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2009 | 44 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 310 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 46 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2009 | 50 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 2555 | 0.080 |
Why?
|
| Citric Acid | 1 | 2009 | 46 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 87 | 0.080 |
Why?
|
| Acute Disease | 2 | 2021 | 857 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1140 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 186 | 0.080 |
Why?
|
| Hematopoiesis | 2 | 2016 | 172 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2009 | 104 | 0.080 |
Why?
|
| Acetylation | 1 | 2009 | 146 | 0.080 |
Why?
|
| Interphase | 2 | 2011 | 37 | 0.080 |
Why?
|
| Metabolic Flux Analysis | 2 | 2019 | 2 | 0.080 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2008 | 22 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 79 | 0.080 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Arginine | 1 | 2008 | 142 | 0.070 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 6 | 0.070 |
Why?
|
| Lysosomes | 1 | 2009 | 117 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 204 | 0.070 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 1476 | 0.070 |
Why?
|
| Dehydroepiandrosterone | 1 | 2008 | 49 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 106 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2010 | 393 | 0.070 |
Why?
|
| K562 Cells | 2 | 2020 | 47 | 0.070 |
Why?
|
| Mitochondrial Membranes | 1 | 2007 | 17 | 0.070 |
Why?
|
| NADP | 2 | 2005 | 49 | 0.070 |
Why?
|
| Gene Expression | 3 | 2020 | 1318 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2020 | 514 | 0.070 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2007 | 29 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2024 | 671 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 612 | 0.070 |
Why?
|
| Imidazoles | 2 | 2018 | 141 | 0.070 |
Why?
|
| RNA | 2 | 2022 | 591 | 0.070 |
Why?
|
| Lactation | 1 | 2006 | 55 | 0.070 |
Why?
|
| Cell Respiration | 2 | 2016 | 21 | 0.060 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2006 | 4 | 0.060 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2019 | 215 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2006 | 28 | 0.060 |
Why?
|
| Keratinocytes | 2 | 2018 | 148 | 0.060 |
Why?
|
| Sirolimus | 1 | 2007 | 173 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 1550 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2005 | 87 | 0.060 |
Why?
|
| Cofilin 1 | 1 | 2025 | 3 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 109 | 0.060 |
Why?
|
| CD36 Antigens | 1 | 2025 | 15 | 0.060 |
Why?
|
| Pertussis Toxin | 1 | 2005 | 32 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 29 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 2 | 2016 | 13 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2082 | 0.060 |
Why?
|
| Protein Binding | 1 | 2009 | 1515 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 57 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2024 | 53 | 0.060 |
Why?
|
| Mexico | 1 | 2024 | 71 | 0.060 |
Why?
|
| Oocytes | 1 | 2005 | 220 | 0.060 |
Why?
|
| Methacholine Chloride | 1 | 2024 | 67 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 605 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1052 | 0.060 |
Why?
|
| Atrophy | 1 | 2005 | 127 | 0.060 |
Why?
|
| Polyps | 1 | 2024 | 28 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2006 | 276 | 0.060 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2024 | 9 | 0.060 |
Why?
|
| Clone Cells | 1 | 2024 | 216 | 0.060 |
Why?
|
| Lactate Dehydrogenases | 1 | 2024 | 3 | 0.060 |
Why?
|
| Lymphopenia | 1 | 2024 | 32 | 0.060 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 556 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 68 | 0.060 |
Why?
|
| Oxygen Consumption | 2 | 2021 | 251 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2021 | 702 | 0.060 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 86 | 0.060 |
Why?
|
| Tumor Escape | 1 | 2024 | 52 | 0.050 |
Why?
|
| Androgens | 1 | 2024 | 176 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2024 | 68 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2024 | 164 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2024 | 502 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 95 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2005 | 202 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 144 | 0.050 |
Why?
|
| Oxygen | 2 | 2019 | 763 | 0.050 |
Why?
|
| NAD | 1 | 2003 | 92 | 0.050 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2022 | 3 | 0.050 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 14 | 0.050 |
Why?
|
| Adipocytes, Brown | 1 | 2022 | 10 | 0.050 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 17 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 50 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2003 | 59 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 105 | 0.050 |
Why?
|
| Cytochromes | 1 | 2022 | 58 | 0.050 |
Why?
|
| Cell Plasticity | 1 | 2022 | 11 | 0.050 |
Why?
|
| fas Receptor | 1 | 2003 | 78 | 0.050 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2022 | 38 | 0.050 |
Why?
|
| Cellular Senescence | 2 | 2016 | 104 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 10 | 0.050 |
Why?
|
| CD40 Antigens | 1 | 2022 | 44 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2022 | 43 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 94 | 0.050 |
Why?
|
| Adenoma | 1 | 2024 | 255 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 141 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 58 | 0.050 |
Why?
|
| Lectins | 1 | 2022 | 86 | 0.050 |
Why?
|
| Ascites | 1 | 2022 | 57 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 129 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 130 | 0.050 |
Why?
|
| Antibodies | 1 | 2024 | 352 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2022 | 295 | 0.050 |
Why?
|
| Autoantigens | 1 | 2022 | 133 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2021 | 26 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 470 | 0.050 |
Why?
|
| Choline | 1 | 2021 | 25 | 0.050 |
Why?
|
| Superoxides | 1 | 2021 | 77 | 0.050 |
Why?
|
| Adrenal Cortex | 1 | 2021 | 22 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 119 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1250 | 0.050 |
Why?
|
| Adipocytes | 1 | 2022 | 170 | 0.050 |
Why?
|
| Nitrates | 1 | 2021 | 36 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2021 | 45 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 457 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 1094 | 0.050 |
Why?
|
| Vitamins | 1 | 2021 | 84 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2022 | 323 | 0.040 |
Why?
|
| G1 Phase | 2 | 2011 | 67 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2020 | 25 | 0.040 |
Why?
|
| Isoantigens | 1 | 2021 | 72 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2022 | 389 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 743 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 905 | 0.040 |
Why?
|
| Heterografts | 1 | 2021 | 107 | 0.040 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 1 | 2020 | 3 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2021 | 104 | 0.040 |
Why?
|
| Listeriosis | 1 | 2021 | 87 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2021 | 89 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 314 | 0.040 |
Why?
|
| Cyclic S-Oxides | 1 | 2020 | 1 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 94 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2016 | 598 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 146 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2021 | 398 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 246 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 273 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 137 | 0.040 |
Why?
|
| Tryptophan | 1 | 2020 | 103 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2021 | 122 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 582 | 0.040 |
Why?
|
| Estrogen Receptor beta | 1 | 2019 | 26 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 485 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 96 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 7 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 142 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 349 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2021 | 379 | 0.040 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 422 | 0.040 |
Why?
|
| Adenoids | 1 | 2018 | 10 | 0.040 |
Why?
|
| Oximes | 1 | 2018 | 17 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2018 | 32 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2022 | 470 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 43 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 1180 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2018 | 39 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 198 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 47 | 0.040 |
Why?
|
| Pyridones | 1 | 2018 | 58 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 98 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 340 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2021 | 960 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2024 | 2509 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 40 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 400 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 19941 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2017 | 13 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 116 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 159 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 154 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 3798 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2018 | 286 | 0.030 |
Why?
|
| Systems Biology | 1 | 2017 | 45 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 196 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 246 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1940 | 0.030 |
Why?
|
| Cell Movement | 1 | 2020 | 797 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Dimethylformamide | 1 | 2016 | 3 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2007 | 277 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 38 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 325 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2016 | 51 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 67 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1404 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 3203 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2015 | 45 | 0.030 |
Why?
|
| Period Circadian Proteins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 69 | 0.030 |
Why?
|
| Oncogenes | 1 | 2016 | 99 | 0.030 |
Why?
|
| Quinolines | 1 | 2016 | 88 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 158 | 0.030 |
Why?
|
| Mitochondrial Size | 1 | 2015 | 4 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 146 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1864 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 173 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 123 | 0.030 |
Why?
|
| Glucosyltransferases | 1 | 2015 | 26 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2015 | 21 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 523 | 0.030 |
Why?
|
| Ceramides | 1 | 2015 | 36 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 276 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 468 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2014 | 45 | 0.030 |
Why?
|
| Machine Learning | 1 | 2017 | 292 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 47 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2015 | 61 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 89 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 174 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 254 | 0.030 |
Why?
|
| Neurons | 1 | 2023 | 1612 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 164 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 149 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2014 | 211 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2013 | 33 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 275 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 375 | 0.030 |
Why?
|
| Microglia | 1 | 2014 | 110 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1506 | 0.030 |
Why?
|
| Food | 1 | 2014 | 92 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 1113 | 0.030 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 13 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3862 | 0.030 |
Why?
|
| Fasting | 1 | 2013 | 167 | 0.030 |
Why?
|
| Child | 1 | 2024 | 7301 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2013 | 35 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 283 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 301 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 321 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 308 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2013 | 127 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 976 | 0.030 |
Why?
|
| 4-Butyrolactone | 1 | 2012 | 4 | 0.030 |
Why?
|
| Fatty Acid Synthases | 1 | 2012 | 9 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 317 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 162 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2015 | 454 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2011 | 14 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 239 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2332 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2013 | 146 | 0.020 |
Why?
|
| Sterols | 1 | 2011 | 17 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 9485 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 43 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2011 | 14 | 0.020 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2011 | 17 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 30 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2011 | 98 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2011 | 40 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1020 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 623 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1185 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 76 | 0.020 |
Why?
|
| Dynamins | 1 | 2011 | 51 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 180 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2013 | 377 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 793 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 185 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 518 | 0.020 |
Why?
|
| ras Proteins | 1 | 2010 | 133 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 474 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6911 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2007 | 68 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 9649 | 0.020 |
Why?
|
| Milk | 1 | 2006 | 54 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2007 | 127 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2446 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1197 | 0.020 |
Why?
|
| Fetus | 1 | 2007 | 234 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 223 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 1392 | 0.020 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2005 | 13 | 0.020 |
Why?
|
| Caspase 2 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Oogenesis | 1 | 2005 | 46 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2005 | 24 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2005 | 141 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 68 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2008 | 340 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2004 | 58 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 42 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 155 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 47 | 0.010 |
Why?
|
| Reproduction | 1 | 2005 | 201 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2002 | 58 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 85 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 8715 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 697 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 167 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 333 | 0.010 |
Why?
|